|
Evaxion A/S
(NASDAQ: EVAX)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $6.21 | Change: -0.24 | %Change: -3.72% | Volume: 70,895 | |
11:10 AM EDT, 04/03/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 1.17% to 1,380.79 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications operator Telefonica (TEF) and consumer goods company Unilever (UL), which rose 5.3% and 4.9% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and brewing company Anheuser-Busch InBev (BUD), which increased 4.7% and 2.6% respectively.
The decliners from continental Europe were led by internet browser company Opera (OPRA) and biotech firm Evaxion Biotech (EVAX), which shed 9.2% and 5.9% respectively. They were followed by internet advertising company Criteo (CRTO), which dropped 8.1%.
From the UK and Ireland, the gainers were led by utility company National Grid (NGG) and pharmaceutical company AstraZeneca (AZN), which were up 6% and 3.8% respectively. They were followed by tobacco company British American Tobacco (BTI) and pharmaceutical company GSK (GSK), which advanced 3.7% and 2.6% respectively.
The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which fell 12.9% and 9.4% respectively. They were followed by financial services company Barclays (BCS) and pharmaceutical company Silence Therapeutics (SLN), which lost 9% and 8.7% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.